MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617078160 A) filed by Aarvik Therapeutics, Inc. on June 24, 2026, for Engineered Antibodies And Immunoconjugates And Methods Of Use.
Inventors include Junutula, Jagath R.; Blazer, Levi L.; Adams, Jarrett; Bhakta, Sunil; and Sidhu, Sachdev Singh.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Provided herein are tetravalent antibodies and immunoconjugates in which the antibodies are conjugated with a payload. The antibodies can comprise a number of different architectures in which paratopes, formed as, for example, Fabs or diabodies, are positioned relative to each other and to an Fc region. Methods of making and using the aforementioned antibodies and immunoconjugates are also provided.
Disclaimer: Curated by HT Syndication.
